Fresenius | FRE - Zysk Brutto Na Sprzedaży





Zysk Brutto Na Sprzedaży Zmiana Data
Akzo Nobel EUR 978M 42M 2026-03
Alcon AG USD 1.68B 16M 2026-06
AstraZeneca USD 12.86B 251M 2026-06
BASF EUR 4.33B 181M 2026-06
Bayer EUR 6.33B 1.84B 2026-06
Beiersdorf EUR 1.54B 1.16B 2025-06
DaVita Healthcare Partners USD 1.16B 266.62M 2026-06
Demant DKK 9.96B 1.13B 2026-06
E.ON EUR 5.41B 672M 2026-03
Essilor EUR 9.41B 1.12B 2026-06
Fresenius EUR 1.55B 16M 2026-06
Fresenius Medical Care EUR 1.31B 130.98M 2026-06
Getinge SEK 4.42B 638M 2026-06
Givaudan CHF 1.55B 140M 2025-12
GlaxoSmithKline GBP 6.51B 757M 2026-06
GN Store Nord DKK 1.13B 116M 2026-06
GRIFOLS EUR 704M 84M 2026-06
Hikma Pharmaceutical USD 362.5M 329.5M 2025-06
Lonza CHF 1.29B 248M 2025-06
Merck EUR 3.17B 101M 2026-06
Novartis USD 11.24B 1.18B 2026-06
Philips EUR 2.15B 384M 2026-06
Roche Holding CHF 22.69B 600M 2026-06
RWE EUR 1.73B 1.02B 2026-03
Sanofi EUR 8.71B 602M 2026-06
Smith & Nephew USD 2.09B 117M 2025-12